期刊文献+

miR-133a真核表达载体的构建及转染大鼠心肌H9C2细胞

Construction of miR-133a eukaryotic expression vector and transfection into H9C2 cell
下载PDF
导出
摘要 目的:构建miR-133a真核表达载体后,体外转染大鼠H9C2心肌细胞。方法:设计并合成DNA模板引物,用T4DNA连接酶将pre-miR-133a连接到线性化的PgenesIL-1.1质粒中,对重组质粒进行酶切及测序鉴定。以Li-pofectamineTM2000 Reagent将鉴定正确的重组质粒瞬时转染H9C2细胞,用流式细胞仪及倒置荧光显微镜检测转染效率。结果:miR-133a真核表达载体符合设计要求,瞬时转染H9C2细胞的转染率达70%以上。结论:成功构建了miR-133a真核表达载体并转染至大鼠心肌H9C2细胞。 Objective: To construct miR-133a eukaryotic expression vector and transfect it into H9C2 cell.Methods: Design and synthetize the PCR templa-primer.Ligate the pre-miR-133a with linearized PgenesIL-1.1 by T4 DNA Ligase.The recombinants were identified by endonuclease digestion and sequenced.Transient transfect the perfect recombinants into H9C2 cells by LipofectamineTM 2000 Reagent.Finally,detect transfection efficiency by flow cytometer and invert fluorescence microscope.Results: The miR-133a eukaryotic expression vectors were consistent with the design and the transfection efficiency of H9C2 cells was 70%.Conclusion: miR-133a eukaryotic expression vector was successfully constructed and transfected into H9C2 cell.
出处 《江苏大学学报(医学版)》 CAS 2011年第1期26-28,49,F0003,共5页 Journal of Jiangsu University:Medicine Edition
关键词 miR-133a 真核表达载体 凋亡 转染 miR-133a eukaryotic expression vector apoptosis transfection
  • 相关文献

参考文献13

  • 1Mishra PK,Tyagi N,Kumar M,et al.MicroRNAs as a therapeutic target for cardiovascular diseases[J].J Cell Mol Med,2009,13(4):778-789.
  • 2van Rooij E,Liu N,Olson EN.MicroRNAs flex their muscles[J].Trends Genet,2008,24(4):159-166.
  • 3van Rooij E,Olson EN.MicroRNAs:powerful new regulators of heart disease and provocative therapeutic targets[J].J Clin Invest,2007,117(9):2369-2376.
  • 4Borchert GM,Lanier W,Davidson BL.RNA polymerase III transcribes human microRNAs[J].Nat Struct Mol Biol,2006,13(12):1097-1101.
  • 5Yi R,Qin Y,Macara IG,et al.Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs[J].Genes Dev,2003,17(24):3011-3016.
  • 6Zhang C.MicroRNAs:role in cardiovascular biology and disease[J].Clin Sci,2008,114(12):699-706.
  • 7Forstemann K,Horwich MD,Wee L,et al.Drosophila microRNAs are sorted into functionally distinct argonaute complexes after production by dicer-1[J].Cell,2007,130(2):287-297.
  • 8Zeng Y,Cullen BR.Sequence requirements for micro RNA processing and function in human cells[J].RNA,2003,9(1):112-123.
  • 9Ikeda S,Kong SW,Lu J,et al.Altered microRNA expression in human heart disease[J].Physiol Genomics,2007,31(3):367-373.
  • 10Chen JF,Mandel EM,Thomson JM,et al.The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and diferentiation[J].Nat Genet,2006,38(2):228-233.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部